vs
美国运通（AXP）与ARS Pharmaceuticals, Inc.（SPRY）财务数据对比。点击上方公司名可切换其他公司
ARS Pharmaceuticals, Inc.的季度营收约是美国运通的1.5倍（$28.1M vs $18.9M），美国运通净利率更高（15.7% vs -147.1%，领先162.8%），美国运通同比增速更快（11.4% vs -67.6%）
美国运通是全球知名的支付服务提供商，主营签账卡、信用卡产品及旅行相关服务，下设全球消费者服务、全球商业服务、全球商户与网络服务三大业务板块，还提供支付融资、网络服务、应付账款费用管理、旅行生活服务等多元解决方案。
ARS Pharmaceuticals是一家处于后期研发阶段的生物制药企业，专注于开发和商业化严重过敏反应创新疗法，核心产品为无需注射的肾上腺素鼻腔递送制剂，主要面向北美市场，服务存在致命过敏风险的成人及儿童患者群体。
AXP vs SPRY — 直观对比
营收规模更大
SPRY
是对方的1.5倍
$18.9M
营收增速更快
AXP
高出79.0%
-67.6%
净利率更高
AXP
高出162.8%
-147.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.9M | $28.1M |
| 净利润 | $3.0M | $-41.3M |
| 毛利率 | — | — |
| 营业利润率 | — | -147.6% |
| 净利率 | 15.7% | -147.1% |
| 营收同比 | 11.4% | -67.6% |
| 净利润同比 | 15.0% | -182.8% |
| 每股收益（稀释后） | — | $-0.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXPSPRY
| Q1 26 | $18.9M | — | ||
| Q4 25 | $10.9B | $28.1M | ||
| Q3 25 | $10.4B | $32.5M | ||
| Q2 25 | $10.3B | $15.7M | ||
| Q1 25 | $9.6B | $8.0M | ||
| Q4 24 | $10.0B | $86.6M | ||
| Q3 24 | $9.7B | $2.1M | ||
| Q2 24 | $9.8B | $500.0K |
净利润AXPSPRY
| Q1 26 | $3.0M | — | ||
| Q4 25 | $2.5B | $-41.3M | ||
| Q3 25 | $2.9B | $-51.2M | ||
| Q2 25 | $2.9B | $-44.9M | ||
| Q1 25 | $2.6B | $-33.9M | ||
| Q4 24 | $2.2B | $49.9M | ||
| Q3 24 | $2.5B | $-19.1M | ||
| Q2 24 | $3.0B | $-12.5M |
营业利润率AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | 28.2% | -147.6% | ||
| Q3 25 | 36.7% | -163.7% | ||
| Q2 25 | 34.4% | -302.9% | ||
| Q1 25 | 34.6% | -466.3% | ||
| Q4 24 | 27.7% | 54.5% | ||
| Q3 24 | 33.0% | -1051.6% | ||
| Q2 24 | 38.6% | -3068.0% |
净利率AXPSPRY
| Q1 26 | 15.7% | — | ||
| Q4 25 | 22.5% | -147.1% | ||
| Q3 25 | 27.9% | -157.4% | ||
| Q2 25 | 28.0% | -285.6% | ||
| Q1 25 | 26.8% | -425.7% | ||
| Q4 24 | 21.8% | 57.7% | ||
| Q3 24 | 25.8% | -925.0% | ||
| Q2 24 | 30.7% | -2503.2% |
每股收益（稀释后）AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | $3.52 | $-0.41 | ||
| Q3 25 | $4.14 | $-0.52 | ||
| Q2 25 | $4.08 | $-0.46 | ||
| Q1 25 | $3.64 | $-0.35 | ||
| Q4 24 | $3.04 | $0.52 | ||
| Q3 24 | $3.49 | $-0.20 | ||
| Q2 24 | $4.15 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $245.0M |
| 总债务越低越好 | $60.4M | $96.4M |
| 股东权益账面价值 | $34.0M | $114.3M |
| 总资产 | $308.9M | $327.7M |
| 负债/权益比越低杠杆越低 | 1.78× | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | $742.0M | $245.0M | ||
| Q3 25 | $1.3B | $288.2M | ||
| Q2 25 | $197.0M | $240.1M | ||
| Q1 25 | $261.0M | $275.7M | ||
| Q4 24 | $221.0M | $314.0M | ||
| Q3 24 | $120.0M | $204.6M | ||
| Q2 24 | $188.0M | $218.7M |
总债务AXPSPRY
| Q1 26 | $60.4M | — | ||
| Q4 25 | $56.4B | $96.4M | ||
| Q3 25 | $57.8B | $96.2M | ||
| Q2 25 | $58.2B | — | ||
| Q1 25 | $51.2B | — | ||
| Q4 24 | $49.7B | $0 | ||
| Q3 24 | $53.5B | — | ||
| Q2 24 | $51.5B | — |
股东权益AXPSPRY
| Q1 26 | $34.0M | — | ||
| Q4 25 | $33.5B | $114.3M | ||
| Q3 25 | $32.4B | $147.7M | ||
| Q2 25 | $32.3B | $192.3M | ||
| Q1 25 | $31.2B | $229.0M | ||
| Q4 24 | $30.3B | $256.8M | ||
| Q3 24 | $29.7B | $201.0M | ||
| Q2 24 | $29.5B | $215.2M |
总资产AXPSPRY
| Q1 26 | $308.9M | — | ||
| Q4 25 | $300.1B | $327.7M | ||
| Q3 25 | $297.6B | $372.8M | ||
| Q2 25 | $295.6B | $313.5M | ||
| Q1 25 | $282.2B | $327.3M | ||
| Q4 24 | $271.5B | $351.2M | ||
| Q3 24 | $271.0B | $217.6M | ||
| Q2 24 | $272.2B | $222.0M |
负债/权益比AXPSPRY
| Q1 26 | 1.78× | — | ||
| Q4 25 | 1.68× | 0.84× | ||
| Q3 25 | 1.78× | 0.65× | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 1.64× | — | ||
| Q4 24 | 1.64× | 0.00× | ||
| Q3 24 | 1.80× | — | ||
| Q2 24 | 1.74× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-43.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $-43.5M | ||
| Q3 25 | $6.2B | $-47.0M | ||
| Q2 25 | $4.4B | $-39.6M | ||
| Q1 25 | $4.8B | $-40.7M | ||
| Q4 24 | $5.8B | $42.0M | ||
| Q3 24 | $-1.8B | $-14.5M | ||
| Q2 24 | $4.5B | $-7.3M |
自由现金流AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | $2.3B | — | ||
| Q3 25 | $5.6B | $-47.2M | ||
| Q2 25 | $3.7B | $-39.6M | ||
| Q1 25 | $4.3B | $-40.8M | ||
| Q4 24 | $5.3B | $41.7M | ||
| Q3 24 | $-2.3B | $-14.6M | ||
| Q2 24 | $4.0B | $-7.3M |
自由现金流率AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | 21.4% | — | ||
| Q3 25 | 53.6% | -145.4% | ||
| Q2 25 | 36.3% | -252.2% | ||
| Q1 25 | 45.0% | -512.1% | ||
| Q4 24 | 53.1% | 48.2% | ||
| Q3 24 | -23.3% | -706.3% | ||
| Q2 24 | 40.4% | -1463.4% |
资本支出强度AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 0.0% | ||
| Q3 25 | 6.3% | 0.6% | ||
| Q2 25 | 6.0% | 0.3% | ||
| Q1 25 | 4.5% | 1.1% | ||
| Q4 24 | 5.0% | 0.3% | ||
| Q3 24 | 4.7% | 6.8% | ||
| Q2 24 | 5.8% | 7.6% |
现金转化率AXPSPRY
| Q1 26 | — | — | ||
| Q4 25 | 1.25× | — | ||
| Q3 25 | 2.15× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 2.66× | 0.84× | ||
| Q3 24 | -0.72× | — | ||
| Q2 24 | 1.50× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
